Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: Results from a nested case-control study

Journal of Child and Adolescent Psychopharmacology

Volumn 21, Issue 4, 2011, Pages 365-368

  Correll, Christoph U ^a,b   Harris, Jennifer ^a   Figen, Vicki ^a,b   Kane, John M ^a,b   Manu, Peter ^a,b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; HALOPERIDOL; MOLINDONE; OLANZAPINE; POTASSIUM; RISPERIDONE; ZIPRASIDONE;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CASE CONTROL STUDY; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBESITY; PATIENT IDENTIFICATION; PSYCHIATRIC DIAGNOSIS; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; SCHIZOPHRENIA; SCREENING; SEX DETERMINATION; SPECTROPHOTOMETRY; T WAVE;

ADOLESCENT; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPOKALEMIA; LONG QT SYNDROME; MALE; MENTAL DISORDERS; OBESITY; RISK FACTORS; SCHIZOPHRENIA;

EID: 80052094008     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2011.0024     Document Type: Article

References (16)

1. Blair J, Scahill L, State M, Martin A: Electrocardiographic changes in children and adolescents treated with ziprasidone: A propsepctive study. J Am Acad Child Adolesc Psychiatry 44:75-79, 2005.
2. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK: Cardiometabolic risk of second generation antipsychotic medications during first-time use in children and adolescents. JAMA 302:1765-1773, 2009.
3. Gajewski KK, Saul JP: Sudden cardiac death in children and adolescents (excluding sudden infant death syndrome). Ann Pediatr Cardiol 3:107-112, 2010.
4. Guven A, Ozgen T, Gungor O, Aydin M, Baysal K: Association between the corrected QT interval and carotid artery intima-media thickness in obese children. J Clin Res Pediatr Endocrinol 2:21-27, 2010.
5. Haase HJ: Zur Dosierung von Neuroleptika. Ein Leitfaden fü r Klinik und Praxis unter Berücksichtigung psychotisch Kranker. Erlangen: Perimed Fachbuch-Verlagsbuchhandlung; 1983.
6. Haddad PM, Anderson IM: Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62:1649-1671, 2002. (Pubitemid 34848372)
7. Lubart E, Segal R, Yearovoi A, Fridenson A, Baumoehl Y, Leibovitz A: QT interval disturbances in hospitalized elderly. Isr Med Assoc J 11:147-150, 2009.
8. Moss AJ: Measurment of the QT interval and the risk associated with QTc interval prolongation: A review. Am J Cardiol 72:23B-25B, 1993. (Pubitemid 23249060)
9. Nigro G, Russo V, Di Salvo G, De Crescenzo I, Rago A, Perrone L, Golino P, Russo MG, Calabro R: Increased heterogeneity of ventricular repolarization in obese nonhypertensive children. Pacing Clin Electrophysiol 33:1533-1539, 2010.
10. Perrin JM, Friedman RA, Knilans TK; Black Box Working Group: Cardiovascular monitoring and stimulant drugs for attention deficit/ hyperactivity disorder. Pediatrics 122:451-453, 2008.
11. Rautarhaju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A: Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 8:690-695, 1999.
12. Varley CK, McClellan J: Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents. JAMA 302:1811-1812, 2009.
13. Vieweg WV: Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs. J Clin Psychiatry 63 Suppl 9:18-24, 2002.
14. Vieweg WV, Wood MA, Fernandez A, Beatty-Brooks M, Hasnain M, Pandurangi AK: Proarrhythmic risk with antipsychotic and antidepressant drugs: Implications in the elderly. Drugs Aging 26:997-1012, 2009.
15. Wilens TE, Biederman J, Baldessarini RJ, Geller B, Scheifer D, Spencer TJ, Birmaher B, Goldblatt A: Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 35:1491-1501, 1996. (Pubitemid 26360935)
16. Woods SW: Chlorpromazine equivalent doses for newer atypical antipsychotics. J Clin Psychiatry 64:663-667, 2003. (Pubitemid 36750143)